$BCLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BRAINSTORM CELL THERAPEUTICS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BRAINSTORM CELL THERAPEUTICS INC.. Get notifications about new insider transactions in BRAINSTORM CELL THERAPEUTICS INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31 2020 | BCLI | BRAINSTORM CELL TH ... | Shah Preetam | EVP, CFO and Treasu ... | Payment of Exercise | F | 4.64 | 25,000 | 116,000 | 11,600 | 36.6 K to 11.6 K (-68.31 %) |
Dec 31 2020 | BCLI | BRAINSTORM CELL TH ... | Shah Preetam | EVP, CFO and Treasu ... | Payment of Exercise | F | 4.64 | 25,000 | 116,000 | 11,600 | 36.6 K to 11.6 K (-68.31 %) |
Nov 19 2020 | BCLI | BRAINSTORM CELL TH ... | Lindborg Stacy | EVP, Head Global Cl ... | Option Exercise | P | 10.00 | 200 | 2,000 | 200 | |
Sep 10 2020 | BCLI | BRAINSTORM CELL TH ... | Waclawski Anthony | See Remarks | Option Exercise | A | 12.58 | 80,000 | 1,006,400 | 80,000 | |
Sep 10 2020 | BCLI | BRAINSTORM CELL TH ... | Waclawski Anthony | See Remarks | Grant | A | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
Jul 31 2020 | BCLI | BRAINSTORM CELL TH ... | Lebovits Chaim | Chief Executive Off ... | Grant | A | 0.00 | 31,185 | 0 | 124,740 | 93.6 K to 124.7 K (+33.33 %) |
Jul 16 2020 | BCLI | BRAINSTORM CELL TH ... | Abbhi Sankesh | Director | Buy | P | 12.99 | 46,779 | 607,659 | 2,164,530 | 2.1 M to 2.2 M (+2.21 %) |
Jul 16 2020 | BCLI | BRAINSTORM CELL TH ... | Setboun David | EVP and COO | Buy | P | 12.95 | 5,000 | 64,740 | 55,000 | 50 K to 55 K (+10.00 %) |
Jul 16 2020 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Sell | S | 13.47 | 7,823 | 105,351 | 67,053 | 74.9 K to 67.1 K (-10.45 %) | |
Jul 16 2020 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Sell | S | 13.12 | 18,430 | 241,715 | 74,876 | 93.3 K to 74.9 K (-19.75 %) | |
Jul 16 2020 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Sell | S | 13.52 | 40,000 | 540,952 | 93,306 | 133.3 K to 93.3 K (-30.01 %) | |
Jul 16 2020 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Sell | S | 13.35 | 2,000 | 26,700 | 133,306 | 135.3 K to 133.3 K (-1.48 %) | |
Jul 16 2020 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Sell | S | 13.13 | 3,500 | 45,939 | 135,306 | 138.8 K to 135.3 K (-2.52 %) | |
Jun 26 2020 | BCLI | BRAINSTORM CELL TH ... | Yablonka Uri | EVP & Chief Busines ... | Grant | A | 0.00 | 10,000 | 0 | 17,543 | 7.5 K to 17.5 K (+132.57 %) |
Jun 01 2020 | BCLI | BRAINSTORM CELL TH ... | Lindborg Stacy | EVP, Head Global Cl ... | Option Exercise | A | 7.67 | 100,000 | 767,000 | 100,000 | |
Jun 01 2020 | BCLI | BRAINSTORM CELL TH ... | Lindborg Stacy | EVP, Head Global Cl ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Apr 07 2020 | BCLI | BRAINSTORM CELL TH ... | Setboun David | EVP and COO | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Apr 07 2020 | BCLI | BRAINSTORM CELL TH ... | FRENKEL JACOB A | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 50,000 | |
Apr 07 2020 | BCLI | BRAINSTORM CELL TH ... | Abbhi Sankesh | Director | Grant | A | 0.00 | 4,657 | 0 | 4,657 | 0 to 4.7 K |
Mar 13 2020 | BCLI | BRAINSTORM CELL TH ... | Kern Ralph Dr. | COO and Chief Medic ... | Option Exercise | A | 7.33 | 80,000 | 586,400 | 80,000 | |
Mar 06 2020 | BCLI | BRAINSTORM CELL TH ... | Kern Ralph Dr. | COO and Chief Medic ... | Grant | A | 0.00 | 35,885 | 0 | 151,540 | 115.7 K to 151.5 K (+31.03 %) |
Feb 14 2020 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 3,071 | 0 | 15,862 | 12.8 K to 15.9 K (+24.01 %) |
Feb 14 2020 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 2,000 | 0 | 12,791 | 10.8 K to 12.8 K (+18.53 %) |
Feb 14 2020 | BCLI | BRAINSTORM CELL TH ... | Almenoff June Sherie | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Dec 27 2019 | BCLI | BRAINSTORM CELL TH ... | Kern Ralph Dr. | COO and Chief Medic ... | Buy | P | 3.88 | 3,000 | 11,640 | 115,655 | 112.7 K to 115.7 K (+2.66 %) |
Dec 27 2019 | BCLI | BRAINSTORM CELL TH ... | Shah Preetam | EVP, CFO and Treasu ... | Buy | P | 3.96 | 11,600 | 45,929 | 36,600 | 25 K to 36.6 K (+46.40 %) |
Dec 27 2019 | BCLI | BRAINSTORM CELL TH ... | Araya Arturo | Chief Commercial Of ... | Buy | P | 3.90 | 3,000 | 11,700 | 8,608 | 5.6 K to 8.6 K (+53.50 %) |
Sep 09 2019 | BCLI | BRAINSTORM CELL TH ... | Shah Preetam | EVP, CFO and Treasu ... | Option Exercise | A | 6.00 | 100,000 | 600,000 | 100,000 | |
Sep 09 2019 | BCLI | BRAINSTORM CELL TH ... | Shah Preetam | EVP, CFO and Treasu ... | Option Exercise | A | 3.96 | 100,000 | 396,000 | 100,000 | |
Sep 09 2019 | BCLI | BRAINSTORM CELL TH ... | Shah Preetam | EVP, CFO and Treasu ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Aug 30 2019 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | M | 2.25 | 6,666 | 14,999 | 0 | |
Aug 30 2019 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | M | 2.25 | 6,666 | 14,999 | 0 | |
Aug 30 2019 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Sell | S | 3.67 | 13,332 | 48,891 | 155,833 | 169.2 K to 155.8 K (-7.88 %) |
Aug 30 2019 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Buy | M | 2.25 | 6,666 | 14,999 | 169,165 | 162.5 K to 169.2 K (+4.10 %) |
Aug 30 2019 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Buy | M | 2.25 | 6,666 | 14,999 | 162,499 | 155.8 K to 162.5 K (+4.28 %) |
Jul 26 2019 | BCLI | BRAINSTORM CELL TH ... | Lebovits Chaim | See Remarks | Grant | A | 0.00 | 31,185 | 0 | 2,166,155 | 2.1 M to 2.2 M (+1.46 %) |
Mar 08 2019 | BCLI | BRAINSTORM CELL TH ... | Kern Ralph Dr. | COO and Chief Medic ... | Grant | A | 0.00 | 35,885 | 0 | 112,655 | 76.8 K to 112.7 K (+46.74 %) |
Feb 22 2019 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 3,501 | 0 | 10,791 | 7.3 K to 10.8 K (+48.02 %) |
Jan 08 2019 | BCLI | BRAINSTORM CELL TH ... | Almenoff June Sherie | Director | Buy | P | 3.39 | 1,475 | 5,000 | 7,175 | 5.7 K to 7.2 K (+25.88 %) |
Dec 21 2018 | BCLI | BRAINSTORM CELL TH ... | Schor Chen | Director | Gift | G | 0.00 | 121,558 | 0 | 121,558 | 0 to 121.6 K |
Dec 21 2018 | BCLI | BRAINSTORM CELL TH ... | Schor Chen | Director | Gift | G | 0.00 | 121,558 | 0 | 4,000 | 125.6 K to 4 K (-96.81 %) |
Nov 30 2018 | BCLI | BRAINSTORM CELL TH ... | Schor Chen | Director | Grant | A | 0.00 | 2,000 | 0 | 125,558 | 123.6 K to 125.6 K (+1.62 %) |
Nov 30 2018 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 1,667 | 0 | 7,290 | 5.6 K to 7.3 K (+29.65 %) |
Nov 30 2018 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 2,000 | 0 | 5,623 | 3.6 K to 5.6 K (+55.20 %) |
Nov 30 2018 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.75 | 25,333 | 19,000 | 25,333 | |
Nov 30 2018 | BCLI | BRAINSTORM CELL TH ... | Yablonka Uri | EVP and Chief Busin ... | Option Exercise | A | 0.75 | 13,333 | 10,000 | 13,333 | |
Nov 30 2018 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Grant | A | 0.00 | 12,000 | 0 | 41,332 | 29.3 K to 41.3 K (+40.91 %) |
Sep 04 2018 | BCLI | BRAINSTORM CELL TH ... | Araya Arturo | Chief Commercial Of ... | Option Exercise | A | 3.98 | 200,000 | 796,000 | 200,000 | |
Sep 04 2018 | BCLI | BRAINSTORM CELL TH ... | Araya Arturo | Chief Commercial Of ... | Sell | D | 0.00 | 2,805 | 0 | 5,608 | 8.4 K to 5.6 K (-33.34 %) |
Jul 27 2018 | BCLI | BRAINSTORM CELL TH ... | Lebovits Chaim | See Remarks | Grant | A | 0.00 | 31,185 | 0 | 2,134,970 | 2.1 M to 2.1 M (+1.48 %) |
Mar 26 2018 | BCLI | BRAINSTORM CELL TH ... | Kern Ralph Dr. | COO and Chief Medic ... | Grant | A | 0.00 | 35,885 | 0 | 76,770 | 40.9 K to 76.8 K (+87.77 %) |
Mar 26 2018 | BCLI | BRAINSTORM CELL TH ... | Araya Arturo | Director | Grant | A | 0.00 | 1,249 | 0 | 8,413 | 7.2 K to 8.4 K (+17.43 %) |
Mar 19 2018 | BCLI | BRAINSTORM CELL TH ... | Kern Ralph Dr. | COO and Chief Medic ... | Grant | A | 3.60 | 5,000 | 17,997 | 40,885 | 35.9 K to 40.9 K (+13.93 %) |
Mar 16 2018 | BCLI | BRAINSTORM CELL TH ... | Almenoff June Sherie | Director | Grant | A | 3.50 | 5,700 | 19,950 | 5,700 | 0 to 5.7 K |
Feb 05 2018 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 3,623 | 0 | 3,623 | 0 to 3.6 K |
Nov 20 2017 | BCLI | BRAINSTORM CELL TH ... | Rubin Eyal | CFO and Treasurer | Option Exercise | A | 4.30 | 93,686 | 402,850 | 93,686 | |
Nov 20 2017 | BCLI | BRAINSTORM CELL TH ... | Rubin Eyal | CFO and Treasurer | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Nov 13 2017 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Grant | A | 0.00 | 8,666 | 0 | 45,731 | 37.1 K to 45.7 K (+23.38 %) |
Nov 13 2017 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Grant | A | 0.00 | 12,000 | 0 | 29,332 | 17.3 K to 29.3 K (+69.24 %) |
Nov 13 2017 | BCLI | BRAINSTORM CELL TH ... | Schor Chen | Director | Grant | A | 0.00 | 2,000 | 0 | 123,558 | 121.6 K to 123.6 K (+1.65 %) |
Aug 31 2017 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Buy | P | 4.26 | 2,500 | 10,650 | 155,833 | 153.3 K to 155.8 K (+1.63 %) |
Aug 23 2017 | BCLI | BRAINSTORM CELL TH ... | Yablonka Uri | EVP & Chief Busines ... | Buy | P | 3.98 | 2,000 | 7,960 | 7,543 | 5.5 K to 7.5 K (+36.08 %) |
Jul 26 2017 | BCLI | BRAINSTORM CELL TH ... | Lebovits Chaim | See Remarks | Option Exercise | A | 4.81 | 41,580 | 200,000 | 41,580 | |
Jul 26 2017 | BCLI | BRAINSTORM CELL TH ... | Lebovits Chaim | See Remarks | Grant | A | 0.00 | 31,185 | 0 | 2,103,785 | 2.1 M to 2.1 M (+1.50 %) |
Jul 17 2017 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.75 | 12,000 | 9,000 | 12,000 | |
Jul 17 2017 | BCLI | BRAINSTORM CELL TH ... | Yablonka Uri | EVP & Chief Busines ... | Grant | A | 0.00 | 5,543 | 0 | 5,543 | 0 to 5.5 K |
Mar 06 2017 | BCLI | BRAINSTORM CELL TH ... | Kern Ralph Dr. | COO and Chief Medic ... | Option Exercise | A | 4.18 | 47,847 | 200,000 | 47,847 | |
Mar 06 2017 | BCLI | BRAINSTORM CELL TH ... | Kern Ralph Dr. | COO and Chief Medic ... | Grant | A | 0.00 | 35,885 | 0 | 35,885 | 0 to 35.9 K |
Mar 03 2017 | BCLI | BRAINSTORM CELL TH ... | Araya Arturo | Director | Grant | A | 0.00 | 3,012 | 0 | 3,012 | 0 to 3 K |
Jun 23 2016 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.75 | 25,333 | 19,000 | 25,333 | |
Jun 23 2016 | BCLI | BRAINSTORM CELL TH ... | Friedman Mordechai | Director | Option Exercise | A | 0.75 | 16,666 | 12,500 | 16,666 | |
Jun 23 2016 | BCLI | BRAINSTORM CELL TH ... | Pinkas Alon | Director | Option Exercise | A | 0.75 | 15,333 | 11,500 | 15,333 | |
Jun 23 2016 | BCLI | BRAINSTORM CELL TH ... | Yablonka Uri | Chief Operating Off ... | Option Exercise | A | 0.75 | 13,333 | 10,000 | 13,333 | |
Jun 23 2016 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Grant | A | 0.00 | 8,666 | 0 | 17,332 | 8.7 K to 17.3 K (+100.00 %) |
Jun 23 2016 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Grant | A | 0.00 | 8,666 | 0 | 37,065 | 28.4 K to 37.1 K (+30.52 %) |
Dec 17 2015 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 2.71 | 10,800 | 29,268 | 28,399 | 39.2 K to 28.4 K (-27.55 %) |
Dec 16 2015 | BCLI | BRAINSTORM CELL TH ... | Friedman Mordechai | Director | Option Exercise | M | 0.75 | 5,000 | 3,750 | 11,666 | |
Dec 16 2015 | BCLI | BRAINSTORM CELL TH ... | Friedman Mordechai | Director | Sell | S | 2.57 | 5,000 | 12,850 | 0 | 5 K to 0 (-100.00 %) |
Dec 16 2015 | BCLI | BRAINSTORM CELL TH ... | Friedman Mordechai | Director | Buy | M | 0.75 | 5,000 | 3,750 | 5,000 | 0 to 5 K |
Dec 16 2015 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 2.59 | 11,263 | 29,171 | 8,666 | 19.9 K to 8.7 K (-56.52 %) |
Dec 16 2015 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 2.61 | 30,479 | 79,550 | 19,929 | 50.4 K to 19.9 K (-60.46 %) |
Dec 14 2015 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 2.56 | 5,300 | 13,568 | 39,199 | 44.5 K to 39.2 K (-11.91 %) |
Dec 14 2015 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 2.71 | 5,500 | 14,905 | 44,499 | 50 K to 44.5 K (-11.00 %) |
Dec 14 2015 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 2.66 | 980 | 2,607 | 50,408 | 51.4 K to 50.4 K (-1.91 %) |
Dec 14 2015 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 2.74 | 12,500 | 34,250 | 51,388 | 63.9 K to 51.4 K (-19.57 %) |
Dec 03 2015 | BCLI | BRAINSTORM CELL TH ... | Bibring Yoram | Chief Financial Off ... | Option Exercise | D | 3.17 | 82,500 | 261,525 | 82,500 | |
Oct 02 2015 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 2.58 | 2,000 | 5,160 | 138,806 | 136.8 K to 138.8 K (+1.46 %) | |
Oct 01 2015 | BCLI | BRAINSTORM CELL TH ... | Lebovits Chaim | See Remarks | Option Exercise | A | 2.45 | 369,619 | 905,567 | 369,619 | |
Oct 01 2015 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 2.34 | 9,200 | 21,528 | 136,806 | 127.6 K to 136.8 K (+7.21 %) | |
Aug 31 2015 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Grant | A | 0.00 | 8,666 | 0 | 49,999 | 41.3 K to 50 K (+20.97 %) |
Aug 31 2015 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Grant | A | 0.00 | 8,666 | 0 | 50,554 | 41.9 K to 50.6 K (+20.69 %) |
Aug 31 2015 | BCLI | BRAINSTORM CELL TH ... | Yablonka Uri | Chief Operating Off ... | Option Exercise | A | 0.75 | 13,333 | 10,000 | 13,333 | |
Aug 31 2015 | BCLI | BRAINSTORM CELL TH ... | Pinkas Alon | Director | Option Exercise | A | 0.75 | 15,333 | 11,500 | 15,333 | |
Aug 31 2015 | BCLI | BRAINSTORM CELL TH ... | Friedman Mordechai | Director | Option Exercise | A | 0.75 | 16,666 | 12,500 | 16,666 | |
Aug 31 2015 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.75 | 25,333 | 19,000 | 25,333 | |
Aug 21 2015 | BCLI | BRAINSTORM CELL TH ... | Bibring Yoram | Chief Financial Off ... | Buy | P | 3.04 | 8,500 | 25,840 | 50,000 | 41.5 K to 50 K (+20.48 %) |
Aug 19 2015 | BCLI | BRAINSTORM CELL TH ... | Bibring Yoram | Chief Financial Off ... | Buy | P | 2.92 | 41,500 | 121,180 | 41,500 | 0 to 41.5 K |
Aug 03 2015 | BCLI | BRAINSTORM CELL TH ... | Bibring Yoram | Chief Financial Off ... | Option Exercise | A | 3.17 | 165,000 | 523,050 | 165,000 | |
Jun 03 2015 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.75 | 6,667 | 5,000 | 6,667 | |
May 05 2015 | BCLI | BRAINSTORM CELL TH ... | Schor Chen | Director | Grant | A | 0.00 | 60,000 | 0 | 121,558 | 61.6 K to 121.6 K (+97.47 %) |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 3.60 | 300 | 1,080 | 2,500 | 2.2 K to 2.5 K (+13.64 %) |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 3.59 | 200 | 718 | 2,200 | 2 K to 2.2 K (+10.00 %) |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.00 | 300 | 1,200 | 127,606 | 127.3 K to 127.6 K (+0.24 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 3.95 | 700 | 2,765 | 127,306 | 126.6 K to 127.3 K (+0.55 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 3.95 | 300 | 1,185 | 126,606 | 126.3 K to 126.6 K (+0.24 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.01 | 400 | 1,604 | 126,306 | 125.9 K to 126.3 K (+0.32 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 3.98 | 400 | 1,592 | 125,906 | 125.5 K to 125.9 K (+0.32 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 3.98 | 1,300 | 5,174 | 125,506 | 124.2 K to 125.5 K (+1.05 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.01 | 600 | 2,406 | 124,206 | 123.6 K to 124.2 K (+0.49 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.04 | 600 | 2,424 | 123,606 | 123 K to 123.6 K (+0.49 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.05 | 300 | 1,215 | 123,006 | 122.7 K to 123 K (+0.24 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.08 | 200 | 816 | 122,706 | 122.5 K to 122.7 K (+0.16 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.09 | 2,500 | 10,225 | 122,506 | 120 K to 122.5 K (+2.08 %) | |
Oct 15 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.29 | 1,000 | 4,290 | 120,006 | 119 K to 120 K (+0.84 %) | |
Oct 01 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.08 | 3,600 | 14,688 | 119,006 | 115.4 K to 119 K (+3.12 %) | |
Oct 01 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.32 | 1,000 | 4,320 | 115,406 | 114.4 K to 115.4 K (+0.87 %) | |
Oct 01 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.22 | 500 | 2,108 | 114,406 | 113.9 K to 114.4 K (+0.44 %) | |
Oct 01 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.12 | 1,000 | 4,120 | 113,906 | 112.9 K to 113.9 K (+0.89 %) | |
Oct 01 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.17 | 500 | 2,085 | 112,906 | 112.4 K to 112.9 K (+0.44 %) | |
Oct 01 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.18 | 100 | 418 | 112,406 | 112.3 K to 112.4 K (+0.09 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.30 | 1,800 | 7,740 | 112,306 | 110.5 K to 112.3 K (+1.63 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.29 | 2,000 | 8,580 | 110,506 | 108.5 K to 110.5 K (+1.84 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.28 | 400 | 1,712 | 108,506 | 108.1 K to 108.5 K (+0.37 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.27 | 1,000 | 4,270 | 108,106 | 107.1 K to 108.1 K (+0.93 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.23 | 1,200 | 5,076 | 107,106 | 105.9 K to 107.1 K (+1.13 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.20 | 500 | 2,100 | 105,906 | 105.4 K to 105.9 K (+0.47 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.18 | 300 | 1,254 | 105,406 | 105.1 K to 105.4 K (+0.29 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.14 | 500 | 2,070 | 105,106 | 104.6 K to 105.1 K (+0.48 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.10 | 300 | 1,230 | 104,606 | 104.3 K to 104.6 K (+0.29 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 4.05 | 500 | 2,025 | 104,306 | 103.8 K to 104.3 K (+0.48 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 3.94 | 1,000 | 3,940 | 103,806 | 102.8 K to 103.8 K (+0.97 %) | |
Sep 24 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 3.90 | 1,500 | 5,850 | 102,806 | 101.3 K to 102.8 K (+1.48 %) | |
Sep 19 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 3.84 | 800 | 3,072 | 2,000 | 1.2 K to 2 K (+66.67 %) |
Sep 16 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 0.28 | 3,000 | 851 | 18,000 | 15 K to 18 K (+20.00 %) |
Sep 16 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 0.29 | 5,000 | 1,438 | 15,000 | 10 K to 15 K (+50.00 %) |
Sep 16 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 0.29 | 7,500 | 2,138 | 10,000 | 2.5 K to 10 K (+300.00 %) |
Sep 16 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 0.28 | 2,500 | 700 | 2,500 | 0 to 2.5 K |
Aug 19 2014 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Grant | A | 0.00 | 130,000 | 0 | 628,333 | 498.3 K to 628.3 K (+26.09 %) |
Aug 19 2014 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Grant | A | 0.00 | 130,000 | 0 | 620,000 | 490 K to 620 K (+26.53 %) |
Aug 19 2014 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.05 | 380,000 | 19,000 | 380,000 | |
Aug 19 2014 | BCLI | BRAINSTORM CELL TH ... | Friedman Mordechai | Director | Option Exercise | A | 0.05 | 250,000 | 12,500 | 250,000 | |
Aug 19 2014 | BCLI | BRAINSTORM CELL TH ... | Yablonka Uri | Chief Operating Off ... | Option Exercise | A | 0.05 | 200,000 | 10,000 | 200,000 | |
Aug 19 2014 | BCLI | BRAINSTORM CELL TH ... | Pinkas Alon | Director | Option Exercise | A | 0.05 | 230,000 | 11,500 | 230,000 | |
Jun 20 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 0.29 | 130,000 | 37,700 | 1,519,600 | 1.4 M to 1.5 M (+9.36 %) | |
Jun 16 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 0.35 | 150,000 | 52,500 | 1,389,600 | 1.2 M to 1.4 M (+12.10 %) | |
Jun 09 2014 | BCLI | BRAINSTORM CELL TH ... | Yablonka Uri | Chief Operating Off ... | Option Exercise | A | 0.18 | 500,000 | 90,000 | 500,000 | |
Jun 10 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Option Exercise | A | 0.30 | 5,700,000 | 1,710,000 | 5,700,000 | |
May 02 2014 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 0.30 | 939,600 | 281,880 | 1,239,600 | 300 K to 1.2 M (+313.20 %) | |
Apr 14 2014 | BCLI | BRAINSTORM CELL TH ... | Israeli Avi | Director | Option Exercise | A | 0.00 | 133,334 | 0 | 133,334 | |
Apr 14 2014 | BCLI | BRAINSTORM CELL TH ... | Israeli Avi | Director | Option Exercise | A | 0.00 | 166,666 | 0 | 166,666 |